Re: Xu et al.: Endophthalmitis after intravitreal injection of vascular endothelial growth factor inhibitors (Ophthalmology. 2018; 125: 1279-1286)

被引：0
|
作者：
Eldeeb, Mohab [1 ]
Hegazy, Omar [2 ]
Eldeeb, Mohamed Ali [3 ]
机构：
[1] St Michaels Hosp, Dept Ophthalmol, Toronto, ON, Canada
[2] Ain Shams Univ, Dept Ophthalmol, Cairo, Egypt
[3] Samaya Specialized Ctr, Dept Ophthalmol, Abu Dhabi, U Arab Emirates
来源：
OPHTHALMOLOGY | 2018年 / 125卷 / 11期
关键词：
VISUAL-ACUITY TEST; COUNTING FINGERS; HAND MOTION;
D O I：
10.1016/j.ophtha.2018.05.025
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E80 / E81
页数：2
相关论文
共 50 条
  • [41] Re: Vogel et al.: Foveal development in infants treated with bevacizumab or laser photocoagulation for retinopathy of prematurity (Ophthalmology. 2018;125:444-452) Reply
    Costakos, Deborah M.
    Vogel, Ryan
    Carroll, Joseph
    [J]. OPHTHALMOLOGY, 2018, 125 (08) : E57 - E57
  • [42] Re: Radhakrishnan et al.: Ophthalmic Technology Assessment: Laser peripheral iridotomy in primary angle closure: a report by the American Academy of Ophthalmology (Ophthalmology. 2018;125:1110-1120)
    Leffler, Christopher T.
    [J]. OPHTHALMOLOGY, 2018, 125 (09) : E59 - E59
  • [43] Re: Wang et al.: Reversal of glaucoma hemifield test results and visual field features in glaucoma (Ophthalmology. 2018;125:352-360) Reply
    Wang, Mengyu
    Pasquale, Louis R.
    Shen, Lucy Q.
    Boland, Michael V.
    Wellik, Sarah R.
    De Moraes, Carlos Gustavo
    Myers, Jonathan S.
    Wang, Hui
    Baniasadi, Neda
    Li, Dian
    Silva, Rafaella Nascimento E.
    Bex, Peter J.
    Elze, Tobias
    [J]. OPHTHALMOLOGY, 2018, 125 (09) : E66 - E67
  • [44] Endophthalmitis after an intravitreal anti-vascular endothelial growth factor injection may unmask a masquerade - A patient with an ocular lymphoma
    Abedi, Farshad
    Borovic, Armand Michael
    Francis, Ian Caithness
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [45] Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226) REPLY
    Lepore, Domenico
    Ji, Marco H.
    Quinn, Graham
    [J]. OPHTHALMOLOGY, 2018, 125 (10) : E71 - E72
  • [46] Re: Bonini et al.: Phase 2 randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis (Ophthalmology. 2018;125:1332-1343)
    Ting, Darren Shu Jeng
    [J]. OPHTHALMOLOGY, 2019, 126 (02) : E14 - E15
  • [47] Re: van Poppelen et al.: Genetic background of iris melanomas and iris melanocytic tumors of uncertain malignant potential (Ophthalmology. 2018; 125: 904-912)
    Scholz, Simone L.
    Murali, Rajmohan
    Westekemper, Henrike
    Schadendorf, Dirk
    Griewank, Klaus G.
    [J]. OPHTHALMOLOGY, 2018, 125 (11) : E78 - E79
  • [48] Re: Zur et al.: OCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implant (Ophthalmology. 2018;125:267-275)
    Srivastav, Khushboo
    Baskaran, Prabu
    [J]. OPHTHALMOLOGY, 2018, 125 (09) : E61 - E61
  • [49] Re: Saxena et al.: Steroids versus no steroids in nonarteritic anterior ischemic optic neuropathy: a randomized controlled trial (Ophthalmology. 2018;125:1623-1627)
    Brown, Sandra M.
    [J]. OPHTHALMOLOGY, 2019, 126 (06) : E46 - E47
  • [50] Re: Wu et al.: Myopia prevention and outdoor light intensity in a school-based cluster randomized trial (Ophthalmology. 2018; 125: 1239-1250)
    Galvis, Virgilio
    Tello, Alejandro
    Maria Gomez, Luz
    Camacho, Paul A.
    Ortiz, Rafael G.
    [J]. OPHTHALMOLOGY, 2018, 125 (11) : E77 - E77
12345